A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

NCT03969329 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism

Interventions

DRUG: Etelcalcetide

Sponsor

Amgen